Thousands of men with prostate cancer could be spared chemotherapy
Thousands of men with prostate cancer could be safely spared chemotherapy, after research found some were not helped by it.
Source: dailymail.co.uk
Research Impact Manager News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Research Impact Manager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Research Impact Manager Today - Breaking & Trending Today
Investegate |Angle PLC Announcements | Angle PLC: Prostate Cancer UK funds new study using Parsortix
Investegate announcements from Angle PLC, Prostate Cancer UK funds new study using Parsortix
Source: investegate.co.uk
ANGLE plc: Angle PLC - Prostate Cancer UK Funds New Study Using Parsortix
Research Into the Use of Parsortix-Based CTC Blood Test To Assess Whether Prostate Cancer Patients Require Prostatectomy SurgeryPotential for a New Standard of Care in an Area of High Unmet Medical NeedGUILDFORD
Source: finanznachrichten.de